Type 2 Drug Seized

May 2005
Diabetes Health;May2005, Vol. 14 Issue 5, p23
Reports on the seizure of oral diabetes medication Avandament and antidepressant Paxil CR from GlaxoSmithLkine in the U.S. in 2005. Reason behind the seizure; Views of the U.S. Food and Drug Administration on the drugs.


Related Articles

  • FDA Gives GSK Angst on Paxil. Edwards, Jim // Brandweek;3/7/2005, Vol. 46 Issue 10, p7 

    Reports on the action taken by the U.S. Food and Drug Administration (FDA) to seize supplies of GlaxoSmithKline (GSK) drugs, anxiety/depression treatment Paxil CR and diabetes treatment Avandamet as of March 7, 2005. Locations of the raids; Failure of the pills to meet the FDA standards;...

  • Largest Woodford holding GSK hit by $3bn fine. Jackson, Gary // Fundweb;7/3/2012, p13 

    The article reports that GlaxoSmithKline (GSK) will have to pay 3 billion dollars for the largest ever health care fraud of the U.S. It states that the company was pleaded guilty for criminal charges for mis-selling of drugs and withholding of data. It mentions that GSK promoted two...

  • GSK: defending its flagship drug.  // PharmaWatch: CNS;August 2003, Vol. 2 Issue 8, p8 

    Reports on the request of GlaxoSmithKline PLC for the U.S. Food and Drug Administration to remove several patents relating to the Paxil antidepressant. Sales of the drug; Schedule of the expiration of the drug's patent; Impact of the expiration on the company.

  • Apotex, GlaxoSmithKline In Generics Battle Over Paxil. Krause, Carey // Chemical Market Reporter;5/21/2001, Vol. 259 Issue 21, p12 

    Reports that Apotex Corp. is seeking an injunction against GlaxoSmithKline (GSK) PLC and the United States (U.S.) Food and Drug Administration over its bid to launch a generic version of Paxil, an anti-depressant. Paxil sales in the U.S. in 2000; Generic equivalent to GSK approved paroxetine...

  • Diabetes drugs linked to vision problems.  // Consumer Reports on Health;May2006, Vol. 18 Issue 5, p7 

    The article reports on the safety information of the diabetes drugs Avandia and Avandamef that was released by the U.S. Food and Drug Administration and GlaxoSmithKline PLC. The drugs were designed to help activate the sugar-regulating hormone insulin in regulating the blood-glucose level and...

  • NEW DOSAGE STRENGTHS.  // Drug Topics;10/6/2003, Vol. 147 Issue 19, p115 

    Reports that GlaxoSmithKline PLC received U.S. Food and Drug Administration approval for two new strengths of its Avandamet brand of rosiglatizone maleate/metformin HCl), a diabetes treatment combining two important medications that, as an adjunct to diet and exercise, significantly lower blood...

  • FDA hearings leave doctors, patients in limbo on Avandia. Eggertson, Laura; Woodward, Cal // CMAJ: Canadian Medical Association Journal;9/7/2010, Vol. 182 Issue 12, pE559 

    The article focuses on the effects of the inquiry made by the U.S. Food and Drug Administration (FDA) on GlaxoSmithKline's Avandia, a drug for type 2 diabetes, to physicians and patients. It relates that the public hearings undertaken by the agency were for the safety profile of rosiglitazone...

  • Characteristics and impact of drug detailing for gabapentin. Steinman, Michael A.; Harper, G. Michael; Chren, Mary-Margaret; Landefeld, C. Seth; Bero, Lisa A. // PLoS Medicine;Apr2007, Vol. 4 Issue 4, pe134 

    Background: Sales visits by pharmaceutical representatives ("drug detailing") are common, but little is known about the content of these visits or about the impact of visit characteristics on prescribing behavior. In this study, we evaluated the content and impact of detail visits...

  • FDA Seizes Drugs Manufactured by Caraco in Michigan. Ramesh, Deepti // Chemical Week;7/6/2009, Vol. 171 Issue 18, p45 

    The article reports on the seizure by U.S. marshals of drug products manufactured by Caraco Pharmaceutical Laboratories at Caraco's facilities in Detroit, Farmington Hills, and Wixom, Michigan. The seizure was mandated by the U.S. Food and Drug Administration (FDA) following Caraco's continued...


Other Topics